(19)

(11)

EP 3 917 968 A1

(12)

(43) Date of publication: 08.12.2021 Bulletin 2021/49 (21) Application number: 19705076.8 (22) Date of filing: 30.01.2019

(51) International Patent Classification (IPC):  C07K 16/32(2006.01) A61K 39/395(2006.01) C07K 16/40(2006.01) A61P 35/00(2006.01) (52) Cooperative Patent Classification (CPC): C07K 2317/24; A61K 39/39558; A61K 2039/545; C07K 16/32; C07K 16/40; A61P 35/00; C07K 2317/734; A61K 2039/505; C07K 2317/34   C-Sets: A61K 39/39558, A61K 2300/00; (86) International application number: PCT/US2019/015900 (87) International publication number: WO 2020/159504 (06.08.2020 Gazette 2020/32)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (71) Applicant: Nomocan Pharmaceuticals LLC New York, NY 10065 (US)	(72) Inventor: SARAFRAZ-YAZDI, Ehsun New York, NY 10021 (US) (74) Representative: Cooley (UK) LLP  22 Bishopsgate London EC2N 4BQ London EC2N 4BQ (GB)